MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
Identifieur interne : 000091 ( Main/Curation ); précédent : 000090; suivant : 000092MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
Auteurs : Irene Litvan [États-Unis] ; Dag Aarsland [Norvège] ; Charles H. Adler [États-Unis] ; Jennifer G. Goldman [États-Unis] ; Jaime Kulisevsky [Espagne] ; Brit Mollenhauer [Allemagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Alexander I. Tröster [États-Unis] ; Daniel Weintraub [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-08-15.
English descriptors
Abstract
There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson's disease. The Movement Disorder Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson's disease–mild cognitive impairment and its association with dementia. A comprehensive PubMed literature review was conducted using systematic inclusion and exclusion criteria. A mean of 26.7% (range, 18.9%–38.2%) of nondemented patients with Parkinson's disease have mild cognitive impairment. The frequency of Parkinson's disease–mild cognitive impairment increases with age, disease duration, and disease severity. Impairments occur in a range of cognitive domains, but single domain impairment is more common than multiple domain impairment, and within single domain impairment, nonamnestic is more common than amnestic impairment. A high proportion of patients with Parkinson's disease–mild cognitive impairment progress to dementia in a relatively short period of time. The primary conclusions of the Task Force are that: (1) Parkinson's disease–mild cognitive impairment is common, (2) there is significant heterogeneity within Parkinson's disease–mild cognitive impairment in the number and types of cognitive domain impairments, (3) Parkinson's disease–mild cognitive impairment appears to place patients at risk of progressing to dementia, and (4) formal diagnostic criteria for Parkinson's disease–mild cognitive impairment are needed. © 2011 Movement Disorder Society
Url:
DOI: 10.1002/mds.23823
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000112
Links to Exploration step
ISTEX:D54A384E259CBCEAF0CE4887C68236F008032EDALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI</title><author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name><affiliation wicri:level="1"><mods:affiliation>Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA, and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, Kentucky, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA, and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, Kentucky</wicri:regionArea></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation wicri:level="1"><mods:affiliation>Centre for Age‐Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Centre for Age‐Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H." last="Adler">Charles H. Adler</name><affiliation wicri:level="1"><mods:affiliation>Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona</wicri:regionArea></affiliation></author><author><name sortKey="Goldman, Jennifer G" sort="Goldman, Jennifer G" uniqKey="Goldman J" first="Jennifer G." last="Goldman">Jennifer G. Goldman</name><affiliation wicri:level="1"><mods:affiliation>Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea></affiliation></author><author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name><affiliation wicri:level="1"><mods:affiliation>Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid</wicri:regionArea></affiliation></author><author><name sortKey="Mollenhauer, Brit" sort="Mollenhauer, Brit" uniqKey="Mollenhauer B" first="Brit" last="Mollenhauer">Brit Mollenhauer</name><affiliation wicri:level="1"><mods:affiliation>Paracelsus‐Elena‐Klinik, Kassel and Georg‐August University Goettingen, Goettingen, Germany</mods:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Paracelsus‐Elena‐Klinik, Kassel and Georg‐August University Goettingen, Goettingen</wicri:regionArea></affiliation></author><author><name sortKey="Rodriguez Roz, Maria C" sort="Rodriguez Roz, Maria C" uniqKey="Rodriguez Roz M" first="Maria C." last="Rodriguez-Oroz">Maria C. Rodriguez-Oroz</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: Current address for Maria C. Rodriguez‐Oroz: Department of Neurology, Hospital Donostia and BioDonostia, San Sebastian, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Current Address: Current address for Maria C. Rodriguez‐Oroz: Department of Neurology, Hospital Donostia and BioDonostia, San Sebastian</wicri:regionArea></affiliation></author><author><name sortKey="Troster, Alexander I" sort="Troster, Alexander I" uniqKey="Troster A" first="Alexander I." last="Tröster">Alexander I. Tröster</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina</wicri:regionArea></affiliation></author><author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name><affiliation wicri:level="1"><mods:affiliation>Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine, and Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine, and Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D54A384E259CBCEAF0CE4887C68236F008032EDA</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23823</idno><idno type="url">https://api.istex.fr/document/D54A384E259CBCEAF0CE4887C68236F008032EDA/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000112</idno><idno type="wicri:Area/Main/Curation">000091</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI</title><author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name><affiliation wicri:level="1"><mods:affiliation>Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA, and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, Kentucky, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA, and Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, Kentucky</wicri:regionArea></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation wicri:level="1"><mods:affiliation>Centre for Age‐Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Centre for Age‐Related Medicine, Stavanger University Hospital and Akershus University Hospital/University of Oslo, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H." last="Adler">Charles H. Adler</name><affiliation wicri:level="1"><mods:affiliation>Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona</wicri:regionArea></affiliation></author><author><name sortKey="Goldman, Jennifer G" sort="Goldman, Jennifer G" uniqKey="Goldman J" first="Jennifer G." last="Goldman">Jennifer G. Goldman</name><affiliation wicri:level="1"><mods:affiliation>Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea></affiliation></author><author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name><affiliation wicri:level="1"><mods:affiliation>Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid</wicri:regionArea></affiliation></author><author><name sortKey="Mollenhauer, Brit" sort="Mollenhauer, Brit" uniqKey="Mollenhauer B" first="Brit" last="Mollenhauer">Brit Mollenhauer</name><affiliation wicri:level="1"><mods:affiliation>Paracelsus‐Elena‐Klinik, Kassel and Georg‐August University Goettingen, Goettingen, Germany</mods:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Paracelsus‐Elena‐Klinik, Kassel and Georg‐August University Goettingen, Goettingen</wicri:regionArea></affiliation></author><author><name sortKey="Rodriguez Roz, Maria C" sort="Rodriguez Roz, Maria C" uniqKey="Rodriguez Roz M" first="Maria C." last="Rodriguez-Oroz">Maria C. Rodriguez-Oroz</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Neurology, Clinic Universidad de Navarra, Medical School, Neuroscience Center, CIMA, Pamplona, Centros de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: Current address for Maria C. Rodriguez‐Oroz: Department of Neurology, Hospital Donostia and BioDonostia, San Sebastian, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Current Address: Current address for Maria C. Rodriguez‐Oroz: Department of Neurology, Hospital Donostia and BioDonostia, San Sebastian</wicri:regionArea></affiliation></author><author><name sortKey="Troster, Alexander I" sort="Troster, Alexander I" uniqKey="Troster A" first="Alexander I." last="Tröster">Alexander I. Tröster</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina</wicri:regionArea></affiliation></author><author><name sortKey="Weintraub, Daniel" sort="Weintraub, Daniel" uniqKey="Weintraub D" first="Daniel" last="Weintraub">Daniel Weintraub</name><affiliation wicri:level="1"><mods:affiliation>Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine, and Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine, and Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-08-15">2011-08-15</date><biblScope unit="volume">26</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1814">1814</biblScope><biblScope unit="page" to="1824">1824</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">D54A384E259CBCEAF0CE4887C68236F008032EDA</idno><idno type="DOI">10.1002/mds.23823</idno><idno type="ArticleID">MDS23823</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>mild cognitive impairment</term><term>systematic review</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson's disease. The Movement Disorder Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson's disease–mild cognitive impairment and its association with dementia. A comprehensive PubMed literature review was conducted using systematic inclusion and exclusion criteria. A mean of 26.7% (range, 18.9%–38.2%) of nondemented patients with Parkinson's disease have mild cognitive impairment. The frequency of Parkinson's disease–mild cognitive impairment increases with age, disease duration, and disease severity. Impairments occur in a range of cognitive domains, but single domain impairment is more common than multiple domain impairment, and within single domain impairment, nonamnestic is more common than amnestic impairment. A high proportion of patients with Parkinson's disease–mild cognitive impairment progress to dementia in a relatively short period of time. The primary conclusions of the Task Force are that: (1) Parkinson's disease–mild cognitive impairment is common, (2) there is significant heterogeneity within Parkinson's disease–mild cognitive impairment in the number and types of cognitive domain impairments, (3) Parkinson's disease–mild cognitive impairment appears to place patients at risk of progressing to dementia, and (4) formal diagnostic criteria for Parkinson's disease–mild cognitive impairment are needed. © 2011 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000091 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000091 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:D54A384E259CBCEAF0CE4887C68236F008032EDA
|texte= MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
}}
| This area was generated with Dilib version V0.6.23. |  |